Providing market intelligence for more than 35 years

In The News

IRobot faces a murky future amid rising Roomba competitors

The company is still “number one,” said Elizabeth Parks, president of market research firm Parks Associates in Dallas. But it’s a shaky number one. Parks estimates that iRobot had nearly two-thirds of the robot vacuum market in 2018, but now holds only a 48 percent share. Meanwhile, rival robot makers like SharkNinja, Roborock, Eufy, and Ecovacs have been steadily chipping away.

One possible reason, according to Parks, is concern about data privacy. More advanced versions of the Roomba and other robots use visual sensors to generate detailed maps of the user’s home. This information is shared with the manufacturers to develop more advanced products, but it could also potentially be used to monitor users.

From the article, "IRobot faces a murky future amid rising Roomba competitors" by Hiawatha Bray

Previously In The News

Slash Your Monthly Internet Bill: 8 Effective Tips to Save Money

According to recent Parks Associates data, US households spend an average of $116 a month on home internet, which is a sizable chunk of change. Whether you use it for remote work, streaming your favor...

Wall Street Wants Streamers to Make More Money – but Consumers Want to Pay Less | Chart

According to Parks Associates, 36% of over-the-top streaming subscribers, or 32 million households, are “service hoppers.” Other analysts call the behavior “subscription cycling.” These customers tend...

Netflix, Inc. (NFLX): William Blair's Bull Case Points To $185 Price Target

William Blair upgraded Netflix, Inc. (NASDAQ:NFLX) to Outperform in August 2016 and believes there continues to be upside potential for the streaming video leader. Through William Blair's research, it...

Apple Looks To Expand Healthcare Presence

“Apple has been enormously successful with its technology and brand power among consumers, so Apple’s entry into the healthcare industry is at least beneficial in raising consumer awareness of excitin...